Premium
Dose adjusted‐ EPOCH ‐R and mediastinal disease may improve outcomes for patients with gray‐zone lymphoma
Author(s) -
Chihara Dai,
Westin Jason R.,
Miranda Roberto N.,
Cheah Chan Y.,
Oki Yasuhiro,
Turturro Francesco,
Romaguera Jorge E.,
Neelapu Sattva S.,
Nastoupil Lorreta J.,
Fayad Luis E.,
Rodriguez M. Alma,
Fowler Nathan H.,
Orlowski Robert Z.,
Wang Michael,
Hagemeister Fredrick B.,
Medeiros L. Jeffrey,
Fanale Michelle A.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14226
Subject(s) - gray (unit) , medicine , epoch (astronomy) , lymphoma , oncology , pediatrics , radiology , astronomy , physics , stars